These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 29741737)
1. Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas. Richardson TE; Sathe AA; Kanchwala M; Jia G; Habib AA; Xiao G; Snuderl M; Xing C; Hatanpaa KJ J Neuropathol Exp Neurol; 2018 Jul; 77(7):542-548. PubMed ID: 29741737 [TBL] [Abstract][Full Text] [Related]
2. Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis. Richardson TE; Snuderl M; Serrano J; Karajannis MA; Heguy A; Oliver D; Raisanen JM; Maher EA; Pan E; Barnett S; Cai C; Habib AA; Bachoo RM; Hatanpaa KJ J Neurooncol; 2017 May; 133(1):183-192. PubMed ID: 28421459 [TBL] [Abstract][Full Text] [Related]
3. Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis. Suwala AK; Stichel D; Schrimpf D; Kloor M; Wefers AK; Reinhardt A; Maas SLN; Kratz CP; Schweizer L; Hasselblatt M; Snuderl M; Abedalthagafi MSJ; Abdullaev Z; Monoranu CM; Bergmann M; Pekrun A; Freyschlag C; Aronica E; Kramm CM; Hinz F; Sievers P; Korshunov A; Kool M; Pfister SM; Sturm D; Jones DTW; Wick W; Unterberg A; Hartmann C; Dodgshun A; Tabori U; Wesseling P; Sahm F; von Deimling A; Reuss DE Acta Neuropathol; 2021 Jan; 141(1):85-100. PubMed ID: 33216206 [TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma. Richardson TE; Walker JM; Hambardzumyan D; Brem S; Hatanpaa KJ; Viapiano MS; Pai B; Umphlett M; Becher OJ; Snuderl M; McBrayer SK; Abdullah KG; Tsankova NM Acta Neuropathol; 2024 Jul; 148(1):5. PubMed ID: 39012509 [TBL] [Abstract][Full Text] [Related]
5. Refinement of prognostication for IDH-mutant astrocytomas using DNA methylation-based classification. Kling T; Ferreyra Vega S; Suman M; Dénes A; Lipatnikova A; Lagerström S; Olsson Bontell T; Jakola AS; Carén H Brain Pathol; 2024 Sep; 34(5):e13233. PubMed ID: 38168467 [TBL] [Abstract][Full Text] [Related]
6. Molecular Signatures of Chromosomal Instability Correlate With Copy Number Variation Patterns and Patient Outcome in IDH-Mutant and IDH-Wildtype Astrocytomas. Richardson TE; Sathe AA; Xing C; Mirchia K; Viapiano MS; Snuderl M; Abdullah KG; Hatanpaa KJ; Walker JM J Neuropathol Exp Neurol; 2021 Mar; 80(4):354-365. PubMed ID: 33755138 [TBL] [Abstract][Full Text] [Related]
7. Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. Shirahata M; Ono T; Stichel D; Schrimpf D; Reuss DE; Sahm F; Koelsche C; Wefers A; Reinhardt A; Huang K; Sievers P; Shimizu H; Nanjo H; Kobayashi Y; Miyake Y; Suzuki T; Adachi JI; Mishima K; Sasaki A; Nishikawa R; Bewerunge-Hudler M; Ryzhova M; Absalyamova O; Golanov A; Sinn P; Platten M; Jungk C; Winkler F; Wick A; Hänggi D; Unterberg A; Pfister SM; Jones DTW; van den Bent M; Hegi M; French P; Baumert BG; Stupp R; Gorlia T; Weller M; Capper D; Korshunov A; Herold-Mende C; Wick W; Louis DN; von Deimling A Acta Neuropathol; 2018 Jul; 136(1):153-166. PubMed ID: 29687258 [TBL] [Abstract][Full Text] [Related]
8. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status. Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492 [TBL] [Abstract][Full Text] [Related]
9. Global DNA methylation profiling reveals chromosomal instability in IDH-mutant astrocytomas. Liu Y; Sathe AA; Abdullah KG; McBrayer SK; Adams SH; Brenner AJ; Hatanpaa KJ; Viapiano MS; Xing C; Walker JM; Richardson TE Acta Neuropathol Commun; 2022 Mar; 10(1):32. PubMed ID: 35264242 [TBL] [Abstract][Full Text] [Related]
10. Diffuse Astrocytoma, IDH-Wildtype: A Dissolving Diagnosis. Hasselblatt M; Jaber M; Reuss D; Grauer O; Bibo A; Terwey S; Schick U; Ebel H; Niederstadt T; Stummer W; von Deimling A; Paulus W J Neuropathol Exp Neurol; 2018 Jun; 77(6):422-425. PubMed ID: 29444314 [TBL] [Abstract][Full Text] [Related]
11. Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review. Lee D; Riestenberg RA; Haskell-Mendoza A; Bloch O J Neurooncol; 2021 Mar; 152(1):89-98. PubMed ID: 33389563 [TBL] [Abstract][Full Text] [Related]
12. IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations. Yang RR; Shi ZF; Zhang ZY; Chan AK; Aibaidula A; Wang WW; Kwan JSH; Poon WS; Chen H; Li WC; Chung NY; Punchhi G; Chu WC; Chan IS; Liu XZ; Mao Y; Li KK; Ng HK Brain Pathol; 2020 May; 30(3):541-553. PubMed ID: 31733156 [TBL] [Abstract][Full Text] [Related]
13. Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma. Satomi K; Ohno M; Matsushita Y; Takahashi M; Miyakita Y; Narita Y; Ichimura K; Yoshida A Mod Pathol; 2021 Apr; 34(4):688-700. PubMed ID: 33077924 [TBL] [Abstract][Full Text] [Related]
14. Establishing a prognostic threshold for total copy number variation within adult IDH-mutant grade II/III astrocytomas. Mirchia K; Snuderl M; Galbraith K; Hatanpaa KJ; Walker JM; Richardson TE Acta Neuropathol Commun; 2019 Jul; 7(1):121. PubMed ID: 31349875 [No Abstract] [Full Text] [Related]
15. Mismatch repair proteins PMS2 and MLH1 can further refine molecular stratification of IDH-mutant lower grade astrocytomas. Yang RR; Li KK; Zhang ZY; Chan AK; Wang WW; Chan DT; Li WC; Liu XZ; Li FC; Chen H; Ng HK; Mao Y; Shi ZF Clin Neurol Neurosurg; 2021 Sep; 208():106882. PubMed ID: 34428613 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas. Galbraith K; Garcia M; Wei S; Chen A; Schroff C; Serrano J; Pacione D; Placantonakis DG; William CM; Faustin A; Zagzag D; Barbaro M; Eibl MDPGP; Shirahata M; Reuss D; Tran QT; Alom Z; von Deimling A; Orr BA; Sulman EP; Golfinos JG; Orringer DA; Jain R; Lieberman E; Feng Y; Snuderl M Neuro Oncol; 2024 Jun; 26(6):1042-1051. PubMed ID: 38243818 [TBL] [Abstract][Full Text] [Related]
17. Integrated molecular characterization of IDH-mutant glioblastomas. Korshunov A; Casalini B; Chavez L; Hielscher T; Sill M; Ryzhova M; Sharma T; Schrimpf D; Stichel D; Capper D; Reuss DE; Sturm D; Absalyamova O; Golanov A; Lambo S; Bewerunge-Hudler M; Lichter P; Herold-Mende C; Wick W; Pfister SM; Kool M; Jones DTW; von Deimling A; Sahm F Neuropathol Appl Neurobiol; 2019 Feb; 45(2):108-118. PubMed ID: 30326163 [TBL] [Abstract][Full Text] [Related]
18. MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas. Wu CC; Jain R; Neto L; Patel S; Poisson LM; Serrano J; Ng V; Patel SH; Placantonakis DG; Zagzag D; Golfinos J; Chi AS; Snuderl M Neuroradiology; 2019 Sep; 61(9):1023-1031. PubMed ID: 31134296 [TBL] [Abstract][Full Text] [Related]
19. Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas. Wong QH; Li KK; Wang WW; Malta TM; Noushmehr H; Grabovska Y; Jones C; Chan AK; Kwan JS; Huang QJ; Wong GC; Li WC; Liu XZ; Chen H; Chan DT; Mao Y; Zhang ZY; Shi ZF; Ng HK Mod Pathol; 2021 Jul; 34(7):1245-1260. PubMed ID: 33692446 [TBL] [Abstract][Full Text] [Related]
20. Radiological Characteristics and Natural History of Adult IDH-Wildtype Astrocytomas with TERT Promoter Mutations. Izquierdo C; Barritault M; Poncet D; Cartalat S; Joubert B; Bruna J; Jouanneau E; Guyotat J; Vasiljevic A; Fenouil T; Berthezène Y; Honnorat J; Meyronet D; Ducray F Neurosurgery; 2019 Sep; 85(3):E448-E456. PubMed ID: 30407589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]